Literature DB >> 27713487

Alzheimer disease: Preclinical Alzheimer disease - the new frontier.

David S Knopman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27713487     DOI： 10.1038/nrneurol.2016.153

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 2.  Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Authors:  Clifford R Jack; David S Knopman; Gaël Chételat; Dennis Dickson; Anne M Fagan; Giovanni B Frisoni; William Jagust; Elizabeth C Mormino; Ronald C Petersen; Reisa A Sperling; Wiesje M van der Flier; Victor L Villemagne; Pieter J Visser; Stephanie J B Vos
Journal:  Nat Rev Neurol       Date:  2016-01-18       Impact factor: 42.937

3.  An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.

Authors:  Clifford R Jack; David S Knopman; Stephen D Weigand; Heather J Wiste; Prashanthi Vemuri; Val Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Robert J Ivnik; Rosebud O Roberts; Walter A Rocca; Bradley F Boeve; Ronald C Petersen
Journal:  Ann Neurol       Date:  2012-04-09       Impact factor: 10.422

Review 4.  Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.

Authors:  Delphine Boche; Nathan Denham; Clive Holmes; James A R Nicoll
Journal:  Acta Neuropathol       Date:  2010-07-15       Impact factor: 17.088

5.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

6.  Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.

Authors:  Samantha C Burnham; Pierrick Bourgeat; Vincent Doré; Greg Savage; Belinda Brown; Simon Laws; Paul Maruff; Olivier Salvado; David Ames; Ralph N Martins; Colin L Masters; Christopher C Rowe; Victor L Villemagne
Journal:  Lancet Neurol       Date:  2016-07-20       Impact factor: 44.182

7.  Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Authors:  Keith A Johnson; Aaron Schultz; Rebecca A Betensky; J Alex Becker; Jorge Sepulcre; Dorene Rentz; Elizabeth Mormino; Jasmeer Chhatwal; Rebecca Amariglio; Kate Papp; Gad Marshall; Mark Albers; Samantha Mauro; Lesley Pepin; Jonathan Alverio; Kelly Judge; Marlie Philiossaint; Timothy Shoup; Daniel Yokell; Bradford Dickerson; Teresa Gomez-Isla; Bradley Hyman; Neil Vasdev; Reisa Sperling
Journal:  Ann Neurol       Date:  2015-12-15       Impact factor: 10.422

8.  Synergistic effect of β-amyloid and neurodegeneration on cognitive decline in clinically normal individuals.

Authors:  Elizabeth C Mormino; Rebecca A Betensky; Trey Hedden; Aaron P Schultz; Rebecca E Amariglio; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  JAMA Neurol       Date:  2014-11       Impact factor: 18.302

9.  Heterogeneity in Suspected Non-Alzheimer Disease Pathophysiology Among Clinically Normal Older Individuals.

Authors:  Elizabeth C Mormino; Kathryn V Papp; Dorene M Rentz; Aaron P Schultz; Molly LaPoint; Rebecca Amariglio; Bernard Hanseeuw; Gad A Marshall; Trey Hedden; Keith A Johnson; Reisa A Sperling
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

10.  Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.

Authors:  Brian A Gordon; Tyler Blazey; Yi Su; Anne M Fagan; David M Holtzman; John C Morris; Tammie L S Benzinger
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302
  10 in total
  2 in total

Review 1.  Radioactive synthesis of tau PET imaging agent 18F-AV-1451 and its role in monitoring the progression of Alzheimer's disease and supporting differential diagnosis.

Authors:  Wenyan Zhang; Shuoyan Xu; Hongmei Yu; Xuena Li; Zhuangzhuang Jin; Yaming Li; Zhiyi He
Journal:  Ann Nucl Med       Date:  2021-01-18       Impact factor: 2.668

Review 2.  TREM2 ectodomain and its soluble form in Alzheimer's disease.

Authors:  Jiaolong Yang; Zhihui Fu; Xingyu Zhang; Min Xiong; Lanxia Meng; Zhentao Zhang
Journal:  J Neuroinflammation       Date:  2020-07-07       Impact factor: 8.322
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.